1. Home
  2. FBGL vs KALA Comparison

FBGL vs KALA Comparison

Compare FBGL & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FBS Global Limited Ordinary Shares

FBGL

FBS Global Limited Ordinary Shares

N/A

Current Price

$2.05

Market Cap

3.0M

ML Signal

N/A

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$0.14

Market Cap

3.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBGL
KALA
Founded
1996
2009
Country
Singapore
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.4M
IPO Year
2022
2017

Fundamental Metrics

Financial Performance
Metric
FBGL
KALA
Price
$2.05
$0.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.3K
★ 208.1K
Earning Date
11-27-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 67.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.07
52 Week High
$4.30
$191.00

Technical Indicators

Market Signals
Indicator
FBGL
KALA
Relative Strength Index (RSI) 43.90 25.29
Support Level $2.04 $0.11
Resistance Level $2.34 $0.35
Average True Range (ATR) 0.13 0.03
MACD -0.03 0.01
Stochastic Oscillator 3.12 0.00

Price Performance

Historical Comparison
FBGL
KALA

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply, and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture, as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and sales of construction materials.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: